Navigation Links
Immune Targeting Systems Completes Second Tranche of Series-A Funding Bringing Total Funds Raised to More Than GBP5m
Date:1/28/2009

LONDON, January 28 /PRNewswire/ -- Immune Targeting Systems (ITS) Limited, a company developing synthetic vaccines for mutating viruses, today announced it has received GBP2.4m of investment as the second tranche of its series-A funding round. ITS's investors HealthCap, the London Technology Fund, Novartis Venture Fund & Truffle Capital provided additional funding to enable a seamless transition into the clinic for the company's universal flu vaccine program which has now entered the GMP pre-clinical phase.

Simultaneously ITS has moved to strengthen its board and management team with the appointment of Brenda Reynolds, a co-founder of PowderMed (acquired by Pfizer in 2006), as company director. Another seasoned vaccine industry professional, Jill Makin, former VP of R&D for Emergent Biosolutions and Microscience, also joins in a consultancy capacity and is responsible for the GMP vaccine manufacture and its release to the clinic.

ITS CEO Carlton Brown commented: "Brenda and Jill are valuable additions to the team and will help drive both our clinical and commercial programs forward. The second tranche of investment brings our total funding to more than GBP5m, including a GBP0.5m development grant from the London Development Agency. We are aiming to raise series-B investment in 2009 to fund our universal influenza vaccine clinical program to proof-of-concept and bring other prioritized candidates through the pipeline. We expect to commence the clinical program by the end of 2009. Despite the current economic climate, our research tells us that the market remains strong for both a successful universal influenza vaccine and therapeutic T-cell vaccine platform."

    Corporate Inquiries
    Carlton Brown; Chief Executive Officer
    Tel +44-7970-944-454, +44-20-7691-4908
    Email: carlton.brown@its-innovation.co.uk


'/>"/>
SOURCE Immune Targeting Systems (ITS) Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Innovative Beverage Products Launches New Product Designed to Enhance the Bodys Immune Defense
2. Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimers Disease Drug Development
3. MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
4. Advances in Detection Technology Drive the European Autoimmune Disease Diagnostics Market
5. IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant
6. MedImmune Announces Zook as President
7. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
8. Visualizing asthma-causing immune cells at work
9. Protein-printing technique gives snapshots of immune system defense
10. Peptimmune Presentations at Upcoming Events
11. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... VILLAGE, Colo. , March 23, 2017  Agriculture ... in Series A financing and note conversion to commercialize ... Cool Planet is focused on developing products that are ... nearly $30 million in the last 18 months. This ... and North Bridge Venture Partners. The ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
(Date:3/22/2017)... ... March 21, 2017 , ... Premier executive recruitment firm, Slone Partners, is ... by Hunt Scanlon Media. , Hunt Scanlon Media is one of the ... global news source in the human capital sector. , “It is a great honor ...
Breaking Biology Technology:
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
(Date:2/24/2017)... Spain , Feb. 24, 2017  EyeLock LLC, a ... demonstrate its elite iris biometric solution on the ... X16 LTE at Mobile World Congress 2017 ... Qualcomm,s Booth in Hall 3, Stand 3E10. ... the Qualcomm Haven™ security platform—a combination of ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):